title: Nanofibrous substrates support colony formation and maintain stemness of human embryonic stem cells.
abstract: Inadequate cell numbers in culture is one of the hurdles currently delaying the application of human embryonic stem cells (hESCs) for transplantation therapy. Nanofibrous scaffolds have been effectively used to expand and differentiate non-colony forming multipotent mesenchymal stem cells (MSC) for the repair of tissues or organs. In the present study, we evaluated the influence of nanofibrous scaffolds for hESC proliferation, increase in colony formation, self-renewal properties, undifferentiation and retention of 'stemness'. Polycaprolactone/collagen (PCL/collagen) and PCL/gelatin nanofibrous scaffolds were fabricated using electrospinning technology. The hESCs were seeded on the nanofibrous scaffolds in the presence or absence of mitomycin-C treated mouse embryonic fibroblasts (MEFs). The hESCs grown on both scaffolds in the presence of the MEFs produced an increase in cell growth of 47.58% (P<or= 0.006) and 40.18% (P<or= 0.005), respectively, over conventional controls of hESCs on MEFs alone. The hESC colonies were also larger in diameter on the scaffolds compared to controls (PCL/collagen, 156.25 +/- 7 microM and PCL/gelatin, 135.42 +/- 5 microM). Immunohistochemistry of the hESCs grown on the nanofibrous scaffolds with MEFs, demonstrated positive staining for the various stemness-related markers (octamer 4 [OCT-4], tumour rejection antigen-1-60, GCTM-2 and TG-30), and semi-quantitative RT-PCR for the pluripotent stemness genomic markers (NANOG, SOX-2, OCT-4) showed that they were also highly expressed. Continued successful propagation of hESC colonies from nanofibrous scaffolds back to conventional culture on MEFs was also possible. Nanofibrous scaffolds support hESC expansion in an undifferentiated state with retention of stemness characteristics thus having tremendous potential in scaling up cell numbers for transplantation therapy.
authors.affiliation: Department of Obstetrics & Gynaecology, Yong Loo Lin School of Medicine, University of Singapore, Singapore.
authors.forename: Kalamegam
authors.initials: K
authors.lastname: Gauthaman
authors.forename: Jayarama Reddy
authors.initials: JR
authors.lastname: Venugopal
authors.forename: Fong Chui
authors.initials: FC
authors.lastname: Yee
authors.forename: Gary Swee Lim
authors.initials: GS
authors.lastname: Peh
authors.forename: Seeram
authors.initials: S
authors.lastname: Ramakrishna
authors.forename: Ariff
authors.initials: A
authors.lastname: Bongso
mesh_terms: D000818:Animals; D018929:Cell Culture Techniques; D049109:Cell Proliferation; D053595:Embryonic Stem Cells / Q000166:cytology*; D005347:Fibroblasts / Q000378:metabolism; D006801:Humans; D051379:Mice; D008855:Microscopy, Electron, Scanning / Q000379:methods; D008858:Microscopy, Phase-Contrast / Q000379:methods; D016685:Mitomycin / Q000494:pharmacology; D057139:Nanofibers; D053758:Nanoparticles / Q000737:chemistry*; D036103:Nanotechnology / Q000379:methods; D020133:Reverse Transcriptase Polymerase Chain Reaction
chemical_list: D016685:Mitomycin